Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
7.81
-0.18 (-2.25%)
May 11, 2026, 10:04 AM EDT - Market open
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $134.17 million as of May 11, 2026. Its market cap has increased by 211.05% in one year.
Market Cap
134.17M
Enterprise Value
108.74M
1-Year Change
211.05%
Ranking
Category
Stock Price
$7.81
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $134.17M, a decrease of -69.27%. That is a compound annual growth rate of -13.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 137.26M | 3.30% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 150.61M |
| TuHURA Biosciences | 148.46M |
| Spero Therapeutics | 147.65M |
| Agenus | 146.30M |
| Equillium | 139.73M |
| Innate Pharma | 138.93M |
| Alps Group | 137.80M |
| Galectin Therapeutics | 137.58M |